Jiangsu Hengrui Pharmaceuticals , China’s biggest drugmaker by market value, reported fourth-quarter profit below market expectations on Wednesday, as income from business development deals ha...
Jiangsu Hengrui Pharmaceuticals , China’s biggest drugmaker by market value, reported fourth-quarter profit below market expectations on Wednesday, as income from business development deals ha...